• About Us
  • Contact Us
  • Email Whitelisting
  • Terms and Conditions
  • Privacy Policy
Wholesome Area - Beauty Secrets and Tips
No Result
View All Result
  • Health Care
  • Health News
  • Healthy Advices
  • Well Being
  • Health Care
  • Health News
  • Healthy Advices
  • Well Being
No Result
View All Result
Wholesome Area - Beauty Secrets and Tips
No Result
View All Result
Home Health Care

Mounjaro and Zepbound no longer in shortage

by
October 3, 2024
in Health Care
0
Mounjaro and Zepbound no longer in shortage
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been resolved.

Tirzepatide, the active ingredient in the diabetes and obesity medications Mounjaro and Zepbound, was declared in shortage in December 2022. The shortage has been attributed to increased demand as interest in GLP-1 medications has soared.

The Food and Drug Administration (FDA) confirmed in a statement Wednesday that the shortage is now considered to be resolved.

“FDA confirmed with the drug’s manufacturer that their stated product availability and manufacturing capacity can meet the present and projected national demand,” the agency said in a statement. “Patients and prescribers may still see intermittent localized supply disruptions as the products move through the supply chain from the manufacturer and distributors to local pharmacies.”

The drug’s shortage status has allowed for compounded versions, which drug manufacturers have derisively referred to as “copycat” versions, to be sold through clinics and telehealth platforms.

These compounded versions have proliferated online, promising consumers the same active ingredient for a fraction of the cost. While compounding pharmacies are FDA-regulated, the products they sell are not and obesity specialists have raised concerns about the widespread availability of these drugs.

In its announcement of the shortage ending, the FDA offered some clarification regarding compounded GLP-1 drugs.

“Compounded drugs are not approved by FDA. FDA-approved drugs go through FDA’s rigorous review for safety, effectiveness, and quality as part of the premarket approval process,” said the agency.

There are two types of compounding pharmacies: 503A and 503B. Telehealth platforms use 503B compounding pharmacies to source their compounded GLP-1s.

The FDA reiterated Wednesday that under the Federal Food, Drug and Cosmetic Act, compounded drugs sold by 503B pharmacies “may not be identical or nearly identical to an FDA-approved drug unless the approved drug is on FDA’s drug shortage list.”

With tirzepatide no longer in shortage, the ability of online companies to sell their compounded versions now falls under question. One such platform, Eden, is still selling its compounded tirzepatide as of Wednesday evening. The Hill has reached out to the company for comment.

Eli Lilly, the manufacturer of tirzepatide, has sued medspas and pharmacies selling compounded versions. The company has previously said it was “deeply concerned about the proliferation of counterfeit, fake, and other unapproved and untested incretin knockoffs.”

The Hill has reached out to Eli Lilly for comment.

Previous Post

Amber Thurman’s family thanks Walz, condemns GOP on abortion

Next Post

Trump, Vance try out new tone on abortion 

Next Post
Trump, Vance try out new tone on abortion 

Trump, Vance try out new tone on abortion 

  • Trending
  • Comments
  • Latest
Americans die younger in states with conservative policies: study

Americans die younger in states with conservative policies: study

October 27, 2022
Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

April 26, 2022
Biden says US has offered vaccines to North Korea but got no response

Biden says US has offered vaccines to North Korea but got no response

May 21, 2022
In Alzheimer’s, DNA errors stress cells, create dysfunction

In Alzheimer’s, DNA errors stress cells, create dysfunction

April 26, 2022
Teens with ‘addictive’ phone use more likely to be suicidal: Study

Teens with ‘addictive’ phone use more likely to be suicidal: Study

0
Authentic Doctors V/S Quacks: Do You Really Know the Difference?

Authentic Doctors V/S Quacks: Do You Really Know the Difference?

0
Top Picks for Meditation Location in the US for a Person with Disability

Top Picks for Meditation Location in the US for a Person with Disability

0
Treat Yourself at the Spa: 7 Health Benefits of Spa Treatments

Treat Yourself at the Spa: 7 Health Benefits of Spa Treatments

0
Teens with ‘addictive’ phone use more likely to be suicidal: Study

Teens with ‘addictive’ phone use more likely to be suicidal: Study

June 20, 2025
ChatGPT use linked to cognitive decline: MIT research

ChatGPT use linked to cognitive decline: MIT research

June 20, 2025
NIH launching long-term health studies of East Palestine train crash

NIH launching long-term health studies of East Palestine train crash

June 19, 2025
Alcohol linked to increased risk of pancreatic cancer: Study

Alcohol linked to increased risk of pancreatic cancer: Study

June 19, 2025

Recent News

Teens with ‘addictive’ phone use more likely to be suicidal: Study

Teens with ‘addictive’ phone use more likely to be suicidal: Study

June 20, 2025
ChatGPT use linked to cognitive decline: MIT research

ChatGPT use linked to cognitive decline: MIT research

June 20, 2025
NIH launching long-term health studies of East Palestine train crash

NIH launching long-term health studies of East Palestine train crash

June 19, 2025
Alcohol linked to increased risk of pancreatic cancer: Study

Alcohol linked to increased risk of pancreatic cancer: Study

June 19, 2025
Enter Your Information Below To Receive Free Health and Beauty Tips and Ideas





    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
    • About Us
    • Contact Us
    • Email Whitelisting
    • Terms and Conditions
    • Privacy Policy
    • About Us
    • Contact Us
    • Email Whitelisting
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
    © 2023 Wholesomearea.com. All rights reserved.

    No Result
    View All Result
    • Health Care
    • Health Medicine
    • Health News
    • Healthy Advices
    • Well Being

    Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
    © 2023 Wholesomearea.com. All rights reserved.